NCT06600009

Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database

Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Database (The FLYWAY Study)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 534 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study was a retrospective non-interventional cohort study with secondary use of data from the Medical Data Vision (MDV) hospital-based database. The study setting was defined as follows: * The inclusion period covered 01 February 2015 to 30 September 2020. * The study period covered 01 August 2014 to 30 September 2021 inclusive. * The index date was defined as the date of the first prescription of secukinumab or adalimumab within the inclusion period. * The pre-index period was defined as the 6-month period before the index date (exclusive). * Patients were followed until death, discontinuation of treatments of interest or end of the study period, whichever occurred first.

Conditions

• Psoriatic Arthritis

Interventions

Type	Name	Description
DRUG	Secukinumab	Patients had received secukinumab per their dosing regimens prior to this observational study.
DRUG	Adalimumab	Patients had received adalimumab per their dosing regimens prior to this observational study.

Timeline

• Start date: 2022-10-17
• Primary completion: 2023-08-21
• Completion: 2023-09-15
• First posted: 2024-09-19
• Last updated: 2024-09-19

Locations

1 site across 1 country: Japan